|
⚲
|
| Keyboard |
| Boyer David W
✚
|
|
|---|---|
| CIK # | 0001909817 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001909817] | |
| 4 | [0001909817] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Boyer David W | |
| Neurocrine Biosciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Tax withheld | 978 | $124.12 | 121,389 |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-13 | Grant | 5,479 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Stock Option · derivative
|
2026-02-13 | Grant | 31,234 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Option exercise | 1,541 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-13 | Option exercise | 1,541 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-13 | Option exercise | 1,811 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Grant | 9,968 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Tax withheld | 5,378 | $124.12 | 667,517 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Tax withheld | 832 | $124.12 | 103,268 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Option exercise | 1,811 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-12 | Tax withheld | 864 | $123.10 | 106,358 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-12 | Option exercise | 1,600 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-12 | Option exercise | 1,600 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restriced Stock Unit · derivative
|
2026-01-31 | Option exercise | 2,096 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-01-31 | Option exercise | 2,096 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-01-31 | Tax withheld | 1,189 | $136.06 | 161,775 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-02-13 | Option exercise | 1,541 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-02-13 | Sell | 955 | $116.79 | 111,534 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-02-13 | Sell | 830 | $116.69 | 96,853 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-02-13 | Option exercise | 1,811 | $0.00 | |
| showing 20 of 57 most recent transactions | |||||